Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

1.9K

Abdominal aortic aneurysm: novel mechanisms and therapies

Frank M Davis1, Debra L Rateri, Alan Daugherty

  • 1aSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan bSaha Cardiovascular Research Center cDepartment of Physiology, University of Kentucky, Lexington, Kentucky, USA.

Current Opinion in Cardiology
|September 10, 2015
PubMed
Abstract

Insights

Abdominal aortic aneurysm (AAA) is a dangerous dilation of the aorta. Recent research highlights genetic factors and inflammatory pathways involved in AAA development, paving the way for new drug therapies.

Area of Science:

  • Cardiovascular Research
  • Genetics and Molecular Biology
  • Pharmacology

Background:

  • Abdominal aortic aneurysm (AAA) is characterized by permanent aortic dilation, posing a risk of fatal rupture.
  • Understanding the underlying mechanisms of AAA pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent advances in understanding AAA pathogenesis.
  • To highlight emerging pharmacologic therapies for AAA.

Main Methods:

  • Review of current human studies and animal models.
  • Analysis of genetic factors and inflammatory mediators implicated in AAA.
  • Examination of preclinical investigations into microRNA-based therapies.

Main Results:

  • Genetic loci such as 3p12.3, DAB2IP, LDLr, LRP1, MMP-3, TGFBR2, and SORT1 are associated with AAA development.
  • Leukocytes and inflammatory mediators (IL-1, IL-17, TGF-β, angiotensin II) play key roles in AAA pathogenesis.
  • MicroRNAs show potential in regulating pathological pathways relevant to AAA.

Conclusions:

  • Recent studies have elucidated numerous potential mechanisms driving AAA pathogenesis.
  • These findings offer promising insights for the development of novel medical treatments for AAA.
  • Ongoing clinical trials aim to translate preclinical discoveries into therapeutic strategies.

More Related Videos

Author Spotlight: Enhanced Murine AAA Model Using Elastase to Mimic Human Aneurysms07:42

Author Spotlight: Enhanced Murine AAA Model Using Elastase to Mimic Human Aneurysms

Published on: July 26, 2024

3.0K
Mouse Abdominal Aortic Aneurysm Model Induced by Perivascular Application of Elastase04:49

Mouse Abdominal Aortic Aneurysm Model Induced by Perivascular Application of Elastase

Published on: February 11, 2022

6.4K

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
450
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
526
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
613
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589